3.59 USD
↗ 0.18 (5.28%)PRE MARKET (AS OF 07:16 AM EDT)
Rocket Pharmaceuticals, Inc. Common Stock
RCKTNASDAQ • USD
Market: OPEN
Rocket Pharmaceuticals, Inc. Common Stock (RCKT) trades at $3.59 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Sep 15, 2026.
Open?$3.36
High?$3.67
Low?$3.36
Prev. Close?$3.41
Volume?31.3K
Avg. Volume?1.5M
VWAP?$3.57
Rel. Volume?0.02x
Bid / Ask
Bid?$2.88 × 100
Ask?$3.45 × 100
Spread?$0.57
Midpoint?$3.17
Valuation & Ratios
Market Cap?374.3M
Shares Out?109.8M
Float?84.6M
Float %?77.5%
P/E Ratio?N/A
P/B Ratio?1.01
EPS?-$0.16
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
Themes
Employees
202
Market Cap
376.5M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-02-18
Address
350 FIFTH AVENUE
NEW YORK, NY 10118
Phone: 646-440-9100
NEW YORK, NY 10118
Phone: 646-440-9100
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?65
Short Sent.?25
Piotroski F-Score?0/9Weak
Altman Z-Score?-1.14Distress
Confidence?54%Low
Short InterestHigh
Short % of Float?17.39%High
Short Interest?14.7M
Days to Cover?9.8
Free Float84.6M
Avg Daily Volume1.5M
Settlement Date2026-08-31
Financial Health
Current Ratio?9.24Strong
Quick Ratio?9.24Strong
Cash Ratio?7.17Strong
Debt/Equity?0.06Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.01CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.9CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-4.7%WEAK▾
S&P11
ROA?-4.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-170394000
Enterprise Value?$171.1M
Fundamentals ratios updated end of day